Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Bisset

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Medicinal Chemistry|May 9, 1997
Folate-based inhibitors of thymidylate synthase: synthesis and antitumor activity of gamma-linked sterically hindered dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583)V Bavetsias, A L Jackman, J H Marriott, et al.
Journal of Medicinal Chemistry|August 1, 1980
Antihypertensive ureidopiperidinesJ L Archibald, D R Beardsley, G M Bisset, et al.
Anti-Cancer Drug Design|December 1, 1996
Prodrugs of thymidylate synthase inhibitors: potential for antibody directed enzyme prodrug therapy (ADEPT)C J Springer, V Bavetsias, A L Jackman, et al.
Journal of Medicinal Chemistry|September 30, 1994
The synthesis and thymidylate synthase inhibitory activity of L-gamma-L-linked dipeptide and L-gamma-amide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583)G M Bisset, V Bavetsias, T J Thornton, et al.
Anti-Cancer Drug Design|October 1, 1995
Quinazoline-based thymidylate synthase inhibitors: relationship between structural modifications and polyglutamationA L Jackman, R Kimbell, M Brown, et al.
Journal of Medicinal Chemistry|November 1, 1990
Quinazoline antifolate thymidylate synthase inhibitors: benzoyl ring modifications in the C2-methyl seriesP R Marsham, A L Jackman, J Oldfield, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Gamma-linked dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8- dideazafolate as antitumour agentsA L Jackman, G M Bisset, D I Jodrell, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Medicinal Chemistry|May 9, 1997
Folate-based inhibitors of thymidylate synthase: synthesis and antitumor activity of gamma-linked sterically hindered dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583)V Bavetsias, A L Jackman, J H Marriott, et al.
Journal of Medicinal Chemistry|August 1, 1980
Antihypertensive ureidopiperidinesJ L Archibald, D R Beardsley, G M Bisset, et al.
Anti-Cancer Drug Design|December 1, 1996
Prodrugs of thymidylate synthase inhibitors: potential for antibody directed enzyme prodrug therapy (ADEPT)C J Springer, V Bavetsias, A L Jackman, et al.
Journal of Medicinal Chemistry|September 30, 1994
The synthesis and thymidylate synthase inhibitory activity of L-gamma-L-linked dipeptide and L-gamma-amide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583)G M Bisset, V Bavetsias, T J Thornton, et al.
Anti-Cancer Drug Design|October 1, 1995
Quinazoline-based thymidylate synthase inhibitors: relationship between structural modifications and polyglutamationA L Jackman, R Kimbell, M Brown, et al.
Journal of Medicinal Chemistry|November 1, 1990
Quinazoline antifolate thymidylate synthase inhibitors: benzoyl ring modifications in the C2-methyl seriesP R Marsham, A L Jackman, J Oldfield, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Gamma-linked dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8- dideazafolate as antitumour agentsA L Jackman, G M Bisset, D I Jodrell, et al.
Pageof 2